Back to AL Alphabet Inc.

GLUEGLUE
Showing 8 of 21 quarters

Position history for ALAlphabet Inc.'s holdings in MONTE ROSA THERAPEUTICS INC

Yes. Alphabet holds 372,474 shares of GLUE (Monte Rosa Therapeutics), worth $9M, as of its Q2 2026 13F filing. It reduced the position by 311,801 shares (-45.6%) from Q1 2026. Alphabet has held GLUE in every 13F on record since Q2 2021, 21 quarterly filings.

Current Value

$9M

Current Shares

372,474

Total Value Change

+$1.3M

Total Shares Change

-1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
372,474
-45.6%
$9M0.0%$24.20
0
2026-Q1
Decreased
684,275
-8.1%
$11.3M0.3%$17.96
0
2025-Q4
Decreased
744,948
-49.1%
$11.7M0.5%$15.97
0
2025-Q3
Unchanged
1.5M
0.0%
$10.8M0.5%$7.31
0
2025-Q2
Unchanged
1.5M
0.0%
$6.6M0.3%$4.60
0
2025-Q1
Unchanged
1.5M
0.0%
$6.8M0.4%$5.10
0
2024-Q4
Unchanged
1.5M
0.0%
$10.2M0.6%$7.02
0
2024-Q3
Unchanged
1.5M
0.0%
$7.8M0.4%$5.17
0

Other major holders of GLUE: PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used